AnaptysBio, Inc.
ANAB · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $235M | $91.3M | +157% |
| Operating income | $47.9M | −$115M | |
| Net income | −$13.2M | −$145M | +90.9% |
Latest quarter: Q1 2026
Form 10-Q · Three months ended Mar 31, 2026 · filed May 12, 2026
| $ | Q1 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $25.6M | $27.8M | −7.9% |
| Operating income | −$34.6M | −$27.5M | −25.8% |
| Net income | −$52.9M | −$39.3M | −34.6% |
Q1 2026 dashboardQ1 2026 infographic
Questions
- What was AnaptysBio's revenue in FY2025?
- $235M in FY2025 (Fiscal year ended Dec 31, 2025), +157% vs $91.3M a year earlier, per its 10-K filed Mar 2026.
- Was AnaptysBio profitable in FY2025?
- No: net income was −$13.2M and operating income $47.9M in FY2025.
- What was AnaptysBio's revenue in Q1 2026?
- $25.6M (−7.9% vs a year earlier), per its Form 10-Q filed May 12, 2026.